Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15799
Abstract: Although several studies have compared the effectiveness and safety of rivaroxaban and apixaban in patients with venous thromboembolism (VTE), direct comparison of these drugs with edoxaban is lacking. read more here.
Keywords: rivaroxaban apixaban; patients venous; apixaban patients; venous thromboembolism ... See more keywords
Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study
Sign Up to like & getrecommendations! Published in 2017 at "Patient preference and adherence"
DOI: 10.2147/ppa.s152579
Abstract: Purpose Patients treated with warfarin must adhere to frequent monitoring, dietary restrictions, and complicated dose adjustments. Apixaban, a direct factor Xa inhibitor, is an alternative to warfarin that may reduce patient burdens associated with warfarin… read more here.
Keywords: satisfaction; warfarin apixaban; switching warfarin; satisfaction switching ... See more keywords
Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data.
Sign Up to like & getrecommendations! Published in 2022 at "Turkish journal of medical sciences"
DOI: 10.55730/1300-0144.5395
Abstract: BACKGROUND This study aims to analyze the real-life data of patients who were prescribed rivaroxaban and apixaban and to emphasize the points that we think will make a difference compared to randomized controlled studies. METHODS… read more here.
Keywords: rivaroxaban apixaban; using rivaroxaban; apixaban patients; patients using ... See more keywords